News

Distribution Partnering Deals in Worldwide Pharma, Biotech and Diagnostics 2014-2020 – ResearchAndMarkets.com

April 9, 2020

DUBLIN–(BUSINESS WIRE)–The “Global Distribution Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014 to 2020” report has been added to ResearchAndMarkets.com’s offering. Global Distribution Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2020 provides details of the latest distribution agreements announced in the pharmaceutical, biotechnology and diagnostic sectors. Trends in distribution dealmaking in…

Details

Global Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2020 – ResearchAndMarkets.com

April 8, 2020

DUBLIN–(BUSINESS WIRE)–The “Global Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2020” report has been added to ResearchAndMarkets.com’s offering. This report provides details of the latest manufacturing and supply agreements announced in the pharmaceutical, biotechnology, device and diagnostic sectors. Fully revised and updated, the report provides details of manufacturing and supply…

Details

AgriScience Labs Elevates Its Compliance Expertise With Addition of Cannabis Trailblazer to Board of Directors

April 8, 2020

DENVER–(BUSINESS WIRE)–AgriScience Labs, one of the oldest ISO-accredited cannabis and hemp testing labs in Colorado, announced today the addition of veteran cannabis regulatory expert Ron Kammerzell to its Board of Directors. Mr. Kammerzell brings three decades of experience in developing state policies and enforcing regulations, including overseeing the rollout of Colorado’s first-in-the-nation recreational cannabis sales.…

Details

Columbia Care Opens in 16th U.S. Jurisdiction with Receipt of Approval to Operate in Virginia

April 8, 2020

NEW YORK–(BUSINESS WIRE)–Columbia Care, Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”) announced that it has received approval from the Virginia Board of Pharmacy to commence vertically integrated operations for the cultivation, manufacture and sale of medical cannabis. The Company also announced the completion of its 65,000 square foot…

Details

Halo Labs Announces the Start of the Superfiltration Program in Cathedral City

April 8, 2020

TORONTO–(BUSINESS WIRE)–Halo Labs Inc. (“Halo” or the “Company“) (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce that the Company has started a pilot superfiltration program of live resin, fats and waxes, tails, terpenes and low grade distillate at Halo’s Coastal Harvest facility in Cathedral City, California. Halo has specialized expertise in cannabis extraction…

Details

Cresco Labs Welcomes Additions to Senior Leadership Team – Crisis-Proven, with the Depth and Experience to Drive Growth at Scale

April 8, 2020

CHICAGO–(BUSINESS WIRE)–Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or “the Company”), one of the largest vertically integrated multistate cannabis operators in the United States, today provided an update on the strategic initiative it has undertaken to increase the strength and depth of the Company’s senior leadership team. These key appointments position the Company to scale rapidly, efficiently,…

Details

cbdMD To Offer Free Hand Sanitizer With Purchase at cbdMD.com

April 8, 2020

CHARLOTTE, N.C.–(BUSINESS WIRE)–cbdMD, Inc. (NYSE American: YCBD, YCBD PR A), a leading cannabidiol (CBD) consumer brand, announced today that in the coming weeks, cbdMD intends to offer third party manufactured single use alcohol-based hand sanitizers (which will not contain CBD) free with the purchase of cbdMD products, while supplies last. Details will be available on…

Details

Halo Labs Announces the Start of the Superfiltration Program in Cathedral City

April 7, 2020

TORONTO–(BUSINESS WIRE)–Halo Labs Inc. (“Halo” or the “Company“) (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce that the Company has started a pilot superfiltration program of live resin, fats and waxes, tails, terpenes and low grade distillate at Halo’s Coastal Harvest facility in Cathedral City, California. Halo has specialized expertise in cannabis extraction…

Details

Calyxt Licenses New Enabling Technology from University of Minnesota for Greater Efficiency in Gene Edited Plants

April 7, 2020

ROSEVILLE, Minn.–(BUSINESS WIRE)–Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, has licensed a new method to help increase plant gene editing efficiency from the University of Minnesota. The method has the potential to reduce the time needed to edit plants from approximately one year to several months. This breakthrough, co-invented by Dan Voytas, Ph.D., the…

Details

Organigram Provides Update on Corporate Action Plan in Response to COVID-19 Pandemic

April 6, 2020

MONCTON, New Brunswick–(BUSINESS WIRE)–Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, today announced the temporary layoff of approximately 45 per cent of its workforce primarily to help boost COVID-19 containment efforts representing approximately 400 employees. “These are unprecedented and trying…

Details

Thailand CBD Regulatory Report 2020: Thailand Seeks to Establish a Clear Legal Framework and Licensing Regime – ResearchAndMarkets.com

April 6, 2020

DUBLIN–(BUSINESS WIRE)–The “Regulatory Report: Thailand Seeks to Establish a Clear Legal Framework and Licensing Regime” report has been added to ResearchAndMarkets.com’s offering. This report provides an invaluable overview of the complex regulatory framework relating to CBD in Thailand. The regulations within this country are restrictive, made worse by the absence of a fully established licensing…

Details

REPEAT/Halo Announces Proposed Acquisition of Nasalbinoid Natural Devices and Concurrent Private Placement

April 6, 2020

TORONTO–(BUSINESS WIRE)–Halo Labs Inc. (“Halo” or the “Company”) (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce it has entered into a definitive agreement (the “Agreement”) all of the common shares of Nasalbinoid Natural Devices Corp. (“Nasalbinoid” or “NND”) for C$5.1 million in Halo common shares at a deemed price of C$0.15 per share…

Details